The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board.
Publication
, Conference
Watson, C; Tait, S; Soo, L; Plichta, JK; Zhang, T; Castellar, E; Armstrong, AJ; Previs, RA; Strickler, JH; Green, M; Datto, M; Marcom, PK ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Watson, C., Tait, S., Soo, L., Plichta, J. K., Zhang, T., Castellar, E., … Menendez, C. S. (2020). The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Watson, Catherine, Sarah Tait, Lindsay Soo, Jennifer Kay Plichta, Tian Zhang, Edgardo Castellar, Andrew J. Armstrong, et al. “The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Watson C, Tait S, Soo L, Plichta JK, Zhang T, Castellar E, et al. The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Watson, Catherine, et al. “The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Watson C, Tait S, Soo L, Plichta JK, Zhang T, Castellar E, Armstrong AJ, Previs RA, Strickler JH, Green M, Datto M, Marcom PK, Menendez CS. The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences